London, United Kingdom

Anthony Robert Milnes Coates

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 1.8

ph-index = 2

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Anthony Robert Milnes Coates

Introduction

Anthony Robert Milnes Coates is a notable inventor based in London, GB. He has made significant contributions to the field of medicine through his innovative work, holding a total of four patents. His research primarily focuses on peptides and their applications in treating various medical conditions.

Latest Patents

Coates' latest patents include "Peptides from chaperonin 60.1," which describes peptides derived from the polypeptide chaperonin 60.1 and their use in medicine for treating inflammatory conditions. Another significant patent is titled "Biological materials and uses thereof," which concerns a peptide molecule or a nucleic acid molecule intended for use in preventing or treating non-cancerous conditions or relieving pain in patients. This invention also encompasses a pharmaceutical composition that includes the peptide or nucleic acid molecule and methods of treatment.

Career Highlights

Throughout his career, Coates has worked with various companies, including Peptinnovate Limited and Helperby Therapeutics Limited. His work in these organizations has contributed to advancements in therapeutic solutions and innovative medical treatments.

Collaborations

Coates has collaborated with several professionals in his field, including Peter Tormay and Yanira Riffo-Vasquez. These collaborations have further enhanced his research and development efforts.

Conclusion

Anthony Robert Milnes Coates is a distinguished inventor whose work in peptide research has the potential to transform medical treatments. His patents reflect a commitment to addressing significant health challenges through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…